Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 205-381-9 | CAS number: 139-89-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Eye irritation
Administrative data
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- April 2013
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP Guideline Study (OECD 437/ EC 440/2008).
Cross-reference
- Reason / purpose for cross-reference:
- reference to same study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 013
- Report date:
- 2013
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 437 (Bovine Corneal Opacity and Permeability Test Method for Identifying Ocular Corrosives and Severe Irritants)
- Deviations:
- not specified
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- EU method B.47 (Bovine corneal opacity and permeability test method for identifying ocular corrosives and severe irritants)
- Deviations:
- not specified
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- other: The Ocular Toxicity Working Group (OTWG) of the ICCVAM and the NICEATM, BRD: current status of in vitro test methods for identifying ocular corrosives and severe irritants: The Bovine Corneal Opacity and Permeability (BCOP) Test Method March 2006.
- Deviations:
- not specified
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- other: In Vitro Techniques in Toxicology Database (INVITTOX) protocol 127. Bovine Opacity and Permeability (BCOP) Assay, 2006.
- Deviations:
- not specified
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- other: Gautheron P., Dukic M., Alix D. and Sina J.F., Bovine corneal opacity and permeability test: An in vitro assay of ocular irritancy. Fundam Appl Toxicol 18:442-449, 1992.
- Principles of method if other than guideline:
- Not applicable.
- GLP compliance:
- yes (incl. QA statement)
Test material
- Reference substance name:
- Trisodium 2-(carboxylatomethyl(2-hydroxyethyl)amino)ethyliminodi(acetate)
- EC Number:
- 205-381-9
- EC Name:
- Trisodium 2-(carboxylatomethyl(2-hydroxyethyl)amino)ethyliminodi(acetate)
- Cas Number:
- 139-89-9
- Molecular formula:
- C10H18N2O7.3Na
- IUPAC Name:
- trisodium [{2-[bis(carboxylatomethyl)amino]ethyl}(2-hydroxyethyl)amino]acetate
- Test material form:
- solid: particulate/powder
- Details on test material:
- - Name of test material: HEDTA-Na3
- Physical state: white crystalline powder
- Analytical purity: 88.6% (as anhydrous form)
- Composition of test material, percentage of components: HEDTA-NA3 x 2.5H2O) = 100.2% (calculated)
- Purity test date: 17 October 2012
- Lot/batch No.: CFC 7826
- Expiration date of the lot/batch: 30 October 2015
- Stability under test conditions: stable
- Storage condition of test material: at room temperature in the dark
Constituent 1
Test animals / tissue source
- Species:
- other: cow
- Details on test animals or tissues and environmental conditions:
- TEST ANIMALS
- Source: bovine eyes from young cattle were obtained from the slaughterhouse (Vitelcos Hertogenbosch, The Netherlands), where the eyes were excised by a slaughterhouse employee as soon as possible after slaughter.
- Transport: Eyes were collected and transported in physiological saline in a suitable container under cooled conditions.
- Preparation of corneas: All eyes were carefully examined for defects by holding the eyes submersed in physiological saline. Those exhibiting unacceptable defects, such as opacity, scratches, pigmentation and neovascularization were discarded. The isolated corneas were stored at 32 +/- 1 degreeC in a petri dish with cMEM (Eagle’s Minimum Essential Medium (Invitrogen Corporation, Breda, The Netherlands) containing 1% (v/v) L-glutamine (Invitrogen Corporation) and 1% (v/v) Foetal Bovine Serum (Invitrogen Corporation)). The isolated corneas were mounted in a corneal holder (one cornea per holder) of MC2 (Clermont, France) with the endothelial side against the O-ring of the posterior half of the holder. The anterior half of the holder was positioned on top of the cornea and tightened with screws. The compartments of the corneal holder were filled with cMEM of 32 +/- 1 degree C. The corneas were incubated for the minimum of 1 hour at 32 +/- 1 degree C.
- All other template details: Not applicable
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 32 +/- 1 degree C
- All other template details: Not applicable
IN-LIFE DATES: Not applicable
Test system
- Vehicle:
- physiological saline
- Controls:
- yes, concurrent vehicle
- Amount / concentration applied:
- TEST MATERIAL
- Amount(s) applied: 750 ul
- Concentration (if solution): 40% w/w, and 100%
VEHICLE
- Source: Merck, Darmstadt, Germany
- All other template details: Not reported - Duration of treatment / exposure:
- 4 hours (240 minutes), +/- 10 minutes
- Observation period (in vivo):
- Immediately after exposure period
- Number of animals or in vitro replicates:
- 3 eyes per treatment
- Details on study design:
- CORNEA SELECTION AND OPACITY READING
After the incubation period, the medium was removed from both compartments and replaced with fresh cMEM. Opacity determinations were performed on each of the corneas using an opacitometer (OP-KIT, MC2, Clermont, France). The opacity of each cornea was read against an air filled chamber, and the initial opacity reading thus determined was recorded. Corneas that had an initial opacity reading higher than 7 were not used. Three corneas were selected at random for each treatment group.
TREATMENT OF CORNEAS AND OPACITY MEASUREMENTS
The medium from the anterior compartment was removed and 750 l of either the negative control, positive control (20% (w/v) Imidazole solution) or 40% (w/w) test substance was introduced onto the epithelium of the cornea. In addition HEDTA-Na3 was weighed in a bottle and applied directly on the corneas in such a way that the cornea was completely covered (302 to 313 mg).The holder was slightly rotated, with the corneas maintained in a horizontal position, to ensure uniform distribution of the solutions over the entire cornea. Corneas were incubated in a horizontal position for 240 10 minutes at 32 1C. After the incubation the solutions and the test compound were removed and the epithelium was washed at least three times with MEM with phenol red (Eagle’s Minimum Essential Medium, Invitrogen Corporation). Possible pH effects of the test substance on the corneas were recorded. The anterior and the posterior compartment were refilled with fresh cMEM and an opacity determination was performed without any further incubation. After the completion of the incubation period each cornea were inspected visually for dissimilar opacity patterns and the opacity determination was performed.
OPACITY MEASUREMENT
The opacitometer determined the difference in the light transmission between each control or treated cornea and an air filled chamber. The numerical opacity value (arbitrary unit) was displayed and recorded. The change in opacity for each individual cornea (including the negative control) was calculated by subtracting the initial opacity reading from the final post-treatment reading. The corrected opacity for each positive control or test substance treated cornea was calculated by subtracting the average change in opacity of the negative control corneas from the change in opacity of each positive control or test substance treated cornea.
The mean opacity value of each treatment group was calculated by averaging the corrected opacity values of the treated corneas for each treatment group.
APPLICATION OF SODIUM FLOURESCEIN
Following the final opacity measurement, permeability of the cornea to Na-fluorescein (Merck) was evaluated.
The medium of both compartments (anterior compartment first) was removed. The posterior compartment was refilled with fresh cMEM. The anterior compartment was filled with 1 ml of 5 mg Na-fluorescein/ml cMEM solution. The holders were slightly rotated, with the corneas maintained in a horizontal position, to ensure uniform distribution of the sodium-fluorescein solution over the entire cornea. Corneas were incubated in a horizontal position for 90 +/- 5 minutes at 32 +/- 1 degree C.
PERMEABILITY DETERMINATIONS
After the incubation period, the medium in the posterior compartment of each holder was removed and placed into a sampling tube labelled according to holder number. 360 l of the medium from each sampling tube was transferred to a 96-well plate. The optical density at 490 nm (OD490) of each sampling tube was measured in triplicate using a microplate reader (TECAN Infinite® M200 Pro Plate Reader). Any OD490 that was 1.500 or higher was diluted to bring the OD490 into the acceptable range (linearity up to OD490 of 1.500 was verified before the start of the experiment). OD490 values of less than 1.500 were used in the permeability calculation.
SCORING SYSTEM:
- The mean opacity and mean permeability values (OD490) were used for each treatment group to calculate an in vitro score: In vitro irritancy score (IVIS) = mean opacity value + (15 x mean OD490 value).
- Additionally the opacity and permeability values were evaluated independently to determine whether the test substance induced irritation through only one of the two endpoints.
- The following in vitro classification system was used for the ocular irritation properties of the test substance as described reference 7.
- A test substance that induces an IVIS ≥ 55.1 is defined as a corrosive or severe irritant. The recommended decision criteria for using the BCOP to identify non-severe irritants are provided in Table 1.
Table 1 Overall BCOP classification criteria
In vitro score range Ìn vitro classification
0 - 3 Non irritant (1)
3.1 - 25 Mild irritant (2)
25.1 - 55 Moderate irritant (3)
≥ 55.1 Severe irritant (4)
(1) EPA Category IV; GHS Not classified; EU Not labelled
(2) EPA Category III; GHS Category 2B; EU Category R36
(3) EPA Category II; GHS Category 2A; EU Category R36
(4) EPA Category I; GHS Category 1; EU Category R41
TOOL USED TO ASSESS SCORE: opacitometer for opacity, fluorescein and microplate reader for permeability
Results and discussion
In vitro
Results
- Irritation parameter:
- in vitro irritation score
- Run / experiment:
- Mean
- Value:
- 58.6
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- other:
- Remarks on result:
- other: 100% HEDTA-Na3
- Other effects / acceptance of results:
- See Table 2 for Summary of opacity, permeability, and in vitro scores.
The corneas were slightly hazy after the 240 minute exposure to HEDTA-Na3 as a 100% solution.
Any other information on results incl. tables
The corneas treated with HEDTA-Na3 ‘as it is’ showed opacity values ranging from -1 to 7 and permeability values ranging from 2.214 to 4.998. The corneas were slightly hazy after the 240 minutes of treatment with HEDTA-Na3 ‘as it is’. Although on one cornea a part of the cornea was clear. No pH effect of the test substance was observed on the rinsing medium. Hence, the in vitro irritancy scores ranged from 37 to 82 after 240 minutes of treatment with HEDTA-Na3 ‘as it is’.
Table 2. Summary of opacity, permeability, and in vitro scores.
Treatment |
Mean Opacity |
Mean Permeability |
MeanIn vitroIrritation Score1, 2 |
Negative control |
0 |
0.000 |
0.0 |
Positive control |
81 |
2.592 |
120 |
HEDTA-Na3 ‘as it is’ |
3 |
3.708 |
58.6 |
1 Calculated using the negative control mean opacity and mean permeability values.
2 In vitro irritancy score (IVIS) = mean opacity value + (15 x mean OD490value).
Applicant's summary and conclusion
- Interpretation of results:
- Category 1 (irreversible effects on the eye)
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Undiluted HEDTA-Na3 (as is) induced severe ocular irritation mainly through the permeability endpoint, resulting in a mean in vitro irritancy score of 59 after 240 minutes of treatment. Since undiluted HEDTA-Na3 induced an IVIS ≥ 55.1, it is concluded that undiluted HEDTA-Na3 tested ‘as is’ is corrosive or severe irritant in the Bovine Corneal Opacity and Permeability test and should be labelled (GSH) as Category 1.
- Executive summary:
Screening for the eye irritancy potential of HEDTA-Na3 has been undertaken using the Bovine Corneal Opacity and Permeability test (BCOP test) based on the most recent OECD and EC test guidelines. The possible ocular irritancy of undiluted HEDTA-Na3 (as is) were tested through topical application for approximately 240 minutes.
Undiluted HEDTA-Na3 (as is) induced severe ocular irritation mainly through the permeability endpoint, resulting in a mean in vitro irritancy score of 59 after 240 minutes of treatment. Since undiluted HEDTA-Na3 induced an IVIS≥55.1, it is concluded that HEDTA-Na3 tested ‘as is’ is corrosive or severe irritant in the Bovine Corneal Opacity and Permeability test and should be labelled (GSH) as Category 1 according to the criteria of Regulation (EC) No. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.